Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of the study was to compare the effect of intravitreal injections of ranibizumab and aflibercept on systemic VEGF protein levels in treatment naïve wet neovascular Age-related Macular Degeneration (wAMD) patients in a detailed time course.
Epistemonikos ID: cd4946d7e79db13bb09ca73ef7765eac82f3266a
First added on: May 12, 2024